ARTICLE
27 December 2019

"Cadillac Tax" On High-Cost Group Health Plans Repealed

PR
Proskauer Rose LLP

Contributor

The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. Our top tier team of star trial attorneys, acclaimed transactional lawyers and exceptionally talented partners and associates have earned a reputation for the relentless pursuit of perfection and a dauntless pursuit of success.
On December 20, 2019, the President signed into law the "Further Consolidated Appropriations Act, 2020" (the "Act").
United States Employment and HR
To print this article, all you need is to be registered or login on Mondaq.com.

On December 20, 2019, the President signed into law the "Further Consolidated Appropriations Act, 2020" (the "Act"). Among many other things, the Act repeals the Affordable Care Act's controversial 40% excise tax on high-cost health care (commonly referred to as the "Cadillac Tax"). From an economic perspective, the Cadillac Tax was intended to generate tax revenue and drive down utilization of unnecessary health care services. Originally scheduled to become effective in 2018, two separate legislative acts pushed the effective date to 2022. Given the Cadillac Tax's unpopularity on both sides of the aisle, it seemed that it was only a matter of time before the tax was repealed.

The Act also repealed two other healthcare-related taxes established by the Affordable Care Act – the medical device tax and the tax on health insurance providers. Both of these taxes were also delayed or paused in prior legislation.

"Cadillac Tax" On High-Cost Group Health Plans Repealed

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More